Biotechnology - Asia-Pacific, Markets & Marketing

Filter

Popular Filters

1 to 25 of 27 results

Seattle Genetics earns $6 million milestone under Adcetris accord with Takeda

Seattle Genetics earns $6 million milestone under Adcetris accord with Takeda

08-04-2014

US biotech firm Seattle Genetics says it will receive milestone payments from Japan’s Takeda Pharmaceutical…

AdcetrisAsia-PacificBiotechnologyFinancialMarkets & MarketingOncologySeattle GeneticsSouth AmericaTakeda Pharmaceuticals

Fast growth forecast for South Korean pharma market

Fast growth forecast for South Korean pharma market

02-04-2014

South Korea's pharmaceuticals market was valued at $20 billion in 2012, growing from $14.5 billion in…

Asia-PacificBiosimilarsBiotechnologyMarkets & MarketingPricingResearch

Mylan gets exclusive rights to distribute Gilead branded drugs in India

Mylan gets exclusive rights to distribute Gilead branded drugs in India

31-01-2014

US generics major Mylan says its India-based subsidiary has been named) exclusive branded medicines business…

AmbisomeAnti-viralsAsia-PacificBiotechnologyGilead SciencesIndiaMarkets & MarketingMylan LaboratoriesStribildTruvadaViread

Lundbeck and Otsuka partner on Biotie’s nalmefene in Japan

Lundbeck and Otsuka partner on Biotie’s nalmefene in Japan

31-10-2013

Biotie Therapies says that its partner, Lundbeck has expanded its existing alliance with Otsuka Pharmaceutical…

Asia-PacificBiotechnologyBiotie TherapiesLicensingLundbeckMarkets & MarketingnalmefeneNeurologicalSelincro

Immutep and Eddingpharm sign accord for ImmuFact IMP321 in China

07-10-2013

French biopharma Immutep and Chinese drugmaker Eddingpharm have entered into an agreement for the development,…

Asia-PacificBiotechnologyLicensingMarkets & MarketingOncologyResearch

First in class novel biologic for psoriasis launched in India

13-08-2013

Bangalore, India-based Biocon (BSE: 532523), Asia's premier biotechnology company, has launched its 'first…

ALZUMAbAsia-PacificBioconBiotechnologyDermatologicalsitolizumabMarkets & Marketing

Japan briefs: Daiichi Sankyo launches silodosin in China; Fujifilm Diosynth UK unit commissioned

22-04-2013

Japanese drug major Daiichi Sankyo says that its subsidiary, Daiichi Sankyo Pharmaceutical (Beijing),…

Asia-PacificBiotechnologyDaiichi SankyoEuropeFujifilm Diosynth BiotechnologiesMarkets & MarketingPharmaceuticalProductionsilodosinUrief

Mylan delivers "one pill once a day" ARV in South Africa; Cipla Debuts first Enbrel biosimilar

17-04-2013

USA-based generic drugmaker Mylan (Nasdaq: MYL) says that it has delivered, through its South African-based…

AmgenAnti-Arthritics/RheumaticsAnti-viralsAsia-PacificBiotechnologyCiplaEnbrelEtaceptGenericsMarkets & MarketingMylan LaboratoriesPfizerRest of the World

Roche teams up with Ascletis on hep C treatments for China

15-04-2013

Roche (ROG: SIX) has entered a collaboration with Ascletis Pharmaceuticals, a USA- and China-based biotech…

Anti-viralsAscletis PharmaceuticalsAsia-PacificBiotechnologydanoprevirLicensingMarkets & MarketingPharmaceuticalResearchRoche

Consultation opens for Australian code of best practice for life science companies

14-03-2013

Trade group AusBiotech and the Australian Securities Exchange (ASX), with the support of the Victorian…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceuticalRegulation

Indian Pharma growth outpaces rivals, but must embrace innovation

12-03-2013

Ranking among the top five globally by production volume, the Indian pharmaceutical market at present…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProductionResearch

Indian pharmaceuticals market led by Ranbaxy in terms of revenue

31-01-2013

The Indian pharmaceutical market is the world's third-largest in terms of volume and stands 14th in terms…

Asia-PacificBioconBiotechnologyGenericsMarkets & MarketingPanacea BiotecPharmaceuticalRanbaxy LaboratoriesSerum Institute of India

Australia's pharma sector a net importer but also one of its largest high-tech exporters

13-01-2013

The pharmaceutical product manufacturing industry in Australia is dominated by major global pharmaceutical…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProduction

Nexavar use in Chinese patients nearly doubled in 2012

19-12-2012

Use of Nexavar (sorafenib, from Bayer [BAYN: DE] and Onyx Pharmaceuticals) has nearly doubled in first-line…

AlimtaAsia-PacificBayerBiotechnologyEli LillyMarkets & MarketingNexavarOncologyPharmaceutical

Uptake of Peg-IFN agents for HCV in China and South Korea hindered by relatively high cost and their partial reimbursement status

21-10-2012

Although pegylated interferon (peg-IFN; Roche's Pegasys, Merck & Co's PegIntron) combined with ribavirin…

Anti-viralsAsia-PacificBiotechnologyIncivekMarkets & MarketingMerck & CoPegasysPegIntronPharmaceuticalRocheVictrelis

Biological launches Japanese Encephalitis vaccine JEEV in India

13-09-2012

Austria's Intercell AG (VSE: ICLL) that its partner, the Indian vaccines and pharma company Biological…

Asia-PacificBiological E LtdBiotechnologyIntercellJEEVMarkets & MarketingPharmaceuticalVaccines

Cancer treatments top breakthrough medicines list, Australian study finds

27-08-2012

A cure for cancer is still to be found but more new treatments have been approved for Australians with…

Asia-PacificBiotechnologyHealthcareMarkets & MarketingPharmaceuticalResearch

Pharmaceutical supply chain in Japan sees squeezed margins

19-07-2012

Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent…

Asia-PacificBiotechnologyFinancialMarkets & MarketingMergers & AcquisitionsPharmaceuticalPricing

Australia's Greens want end to Big Pharma inducements

28-06-2012

Ahead of an announcement by pharma trade group Medicines Australia on a new Code of Conduct this week,…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceuticalRegulation

CSL Biotherapies indentifies likely reason for Fluvax problems

21-06-2012

Australia's largest biotech firm CSL Biotherapies, a division of CSL Limited (ASX: CSL) today presented…

Asia-PacificBiotechnologyCSL BiotherapiesCSL LimitedFluvaxMarkets & MarketingVaccines

Business in Japan versus to Japan, by P Reed Maurer

11-06-2012

A pharmaceutical company without a presence in Japan but with a hot new product ready for Phase III clinical…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceuticalRegulation

Erythropoietin market in Japan to reach $1.54 billion by 2015

20-05-2012

The erythropoietin market in Japan is forecast to reach $1.54 billion by 2015 by analysts at TechNavio.…

Asia-PacificBiotechnologyGenericsMarkets & MarketingNephrology and HepatologyPatents

Contract manufacturing in India and China backed by government policies

16-05-2012

Contract Manufacturing Organizations (CMO) will reap the rewards as pharmaceutical production becomes…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceutical

1 to 25 of 27 results

Back to top